Molecular typing is predicated on molecular genetic testing and is not still routinely readily available. Molecular subtypes and immunohistochemical surrogate markers on the tumors (HR, HER2, triple negative) correlate in about 70%. The differentiation of luminal A and B subtypes by HR standing and proliferation markers like Ki-sixty seven https://alexisb197cmv6.wikistatement.com/user